TickerKhojComparison · NSE · data 2026-11-03
Senores Pharmaceuticals Ltd. vs SMS Pharmaceuticals Limited
In plain words
Size: Senores Pharmaceuticals Ltd. is about 1.1 times the market value of SMS Pharmaceuticals Limited.
Valuation (P/E): SMS Pharmaceuticals Limited 45.6 vs Senores Pharmaceuticals Ltd. 39.7.
Debt to equity: SMS Pharmaceuticals Limited 0.46 vs Senores Pharmaceuticals Ltd. 0.37.
Differences in the numbers, not a recommendation of either stock.
Side by side
19 metrics shown
| SENORES | SMSPHARMA | |
|---|---|---|
| Price | ₹1,147 | ₹514.15 |
| Market cap | ₹5,157 cr | ₹4,722 cr |
| P/E | 39.7 | 45.6 |
| P/B | 5.3 | — |
| ROE | 13.4% | 14.3% |
| ROCE | 12.6% | 13.9% |
| Debt / equity | 0.37 | 0.46 |
| Operating margin | 24.3% | 14.8% |
| Dividend yield | 0.00% | 0.08% |
| Sales growth, 3 years (yearly) | 161.6% | 19.3% |
| Profit growth, 3 years (yearly) | 139.2% | — |
| 1-year return | 48.7% | 81.1% |
| Revenue, last 12 months | ₹722 cr | ₹898 cr |
| Net profit, last 12 months | ₹133 cr | ₹102 cr |
| Latest quarter | Sept 2026 | Jun 2026 |
| Quarter net profit | ₹39 cr | ₹21 cr |
| Quarter profit vs a year earlier | +22.0% | +2.0% |
| Promoter holding | 45.82% | 68.07% |
| Health check | Strong (7.2/10) | Strong (7.1/10) |
Common questions
Which has a higher P/E, Senores Pharmaceuticals Ltd. or SMS Pharmaceuticals Limited?
SMS Pharmaceuticals Limited trades at the higher P/E (45.6 against 39.7). A higher P/E means the market pays more for each rupee of past earnings; on its own it does not say which is better.
Which earns a higher return on equity?
SMS Pharmaceuticals Limited (14.3% against 13.4%).
Which carries more debt?
SMS Pharmaceuticals Limited has the higher debt-to-equity ratio (0.46 against 0.37).